Quest Diagnostics Declares Quarterly Cash Dividend
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) announced that its Board of Directors has declared a quarterly cash dividend of $0.86 per share.
The dividend is payable on July 22, 2026 to shareholders of record as of July 8, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Positive
- Quarterly cash dividend of $0.86 per share declared
- Dividend payable on July 22, 2026
- Shareholders of record on July 8, 2026 eligible for payment
Negative
- None.
News Market Reaction – DGX
On the day this news was published, DGX gained 1.30%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302776544.html
SOURCE Quest Diagnostics